Internal Medicine, Medical Oncology · Boston, MA
NPI
1750344008
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
44 Binney St SW 430, Dfci Head and Neck Oncology
Boston, MA, 02115
Phone (617) 632-3090
Groups this clinician bills Medicare through
Medicare paid, 2024
$52K
717 services
Medicare patients, 2024
211
Average age 73
Drug cost, 2024
$2.1M
255 prescriptions
Company payments, 2025
$50K
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lori J Wirth was code 99215 (office e&m - established), 132 times for 78 patients. In total Lori J Wirth billed 717 services in 13 codes, and Medicare paid $52K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-11-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 132 | 78 | $112.75 | $15K |
| 99215 Office E&M - Established | Office | 103 | 45 | $116.63 | $12K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 82 | 58 | $13.82 | $1,133 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 76 | 45 | $13.18 | $1,002 |
| 99233 Hospital E&M - Subsequent | Facility | 49 | 25 | $98.21 | $4,812 |
| 99214 Office E&M - Established | Office | 48 | 34 | $77.15 | $3,703 |
| 99214 Office E&M - Established | Facility | 41 | 35 | $75.36 | $3,090 |
| 99232 Hospital E&M - Subsequent | Facility | 41 | 21 | $65.46 | $2,684 |
| 31575 Other Organ Systems | Facility | 23 | 21 | $56.69 | $1,304 |
| 31575 Other Organ Systems | Office | 22 | 20 | $54.87 | $1,207 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 21 | 16 | $26.19 | $550 |
| 99223 Hospital E&M - Initial | Facility | 17 | 17 | $144.07 | $2,449 |
By year: 2022 $50K for 541 services; 2023 $50K for 550 services; 2024 $52K for 717 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lori J Wirth prescribed most often to Medicare patients was Lenvima (Lenvatinib Mesylate), with 51 prescriptions and refills. In total Lori J Wirth wrote 255 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lenvima Lenvatinib Mesylate | 51 | 51 | 14 | $1.2M |
| Levothyroxine Sodium Generic | 39 | 74 | 12 | $246 |
| Retevmo Selpercatinib | 16 | 16 | Under 11 | $317K |
| Mekinist Trametinib Dimethyl Sulfoxide | 14 | 14 | Under 11 | $209K |
| Tafinlar Dabrafenib Mesylate | 13 | 15 | Under 11 | $187K |
| Amlodipine Besylate Generic | 11 | 19 | Under 11 | $25.86 |
Brand drugs: 118 claims; generic drugs: 137 claims; opioid claims: 21.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lori J Wirth $50K ($49K in general payments such as food, travel and fees and $957 for research) from 11 companies. The largest payer was LEO Pharma AS with $17K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.